The present application includes purine compounds of Formula I or II: or a pharmaceuticallyacceptable salt, solvate, and/or ester thereof, compositions containing suchcompounds, therapeutic methods that include the administration of such compounds,and therapeutic methods that include the administration of such compounds withat least one additional active agent. Said compounds are used as modulators ofToll -like receptor 7.